Nucleai
Lotan Chorev is a seasoned professional in the field of research and development, currently serving as Co-Founder and VP R&D at Nucleai since 2017. Under Lotan's leadership, Nucleai has emerged as a prominent provider of an AI-powered precision oncology platform that enhances biomarker discovery and informs treatment decisions, ultimately improving patient care and clinical trial effectiveness. Prior to Nucleai, Lotan held the position of VP R&D at SpacePharma from 2014 to 2017, and served as CTO at Nooly between 2010 and 2013. Lotan's career began in the IDF, where responsibilities included System Engineer, Software Team Lead, and Software Engineer from 2003 to 2010. Lotan Chorev earned a Bachelor of Science degree in Electrical Engineering from the Technion - Israel Institute of Technology between 1998 and 2002.
This person is not in any offices
Nucleai
7 followers
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes. Nucleai’s platform leverages unique tissue datasets to produce insights into cancer biology, increasing clinical trial efficacy and improving patient care. Nucleai works with leading pharmaceutical companies,licensing its research platform for internal use, and collaborating in biomarkers discovery projects.